5Malini PL, Stroechi E, Zarandi M, et al. Thremboxane antagonism and cough induced by angiotensin converting-enzyme inhibitor[J].Lancet, 1997,350(9070) :15.
6Navookarasu NT, Rahman AR, Abdullah I, et al. First-dose response to angiotensin converting enzyme inhibition in congestive cardiac failure: a Malaysian experience[ J ]. Int J Clin Pract, 1999,53 : 25-30.
7Robins SJ. Fibrates and conmnaryheart disease reduction in diabetes[ J]. Curt Opin Endocrinol Diabetes,2002,9:312 - 322.
8Cusi K. Cardiovascular risk management in type 2 diabetes:from clinical trials toclinical practice [ J ]. Endocrinologist,2001,11:474 -490.
9UK Prospective Diabetes Study (UKP-DS) Group. Intensive blood - glucosecontrol with sulphonylureas or insulin compared with conventional treatmentand risk complications in patients with type 2 diabetes( UKPDS 33 ) [ J]. Lancet, 1998, 352:837 - 853.
10Vlassara H. Recent progress in advanced glycation end products and diabetic complications [ J ]. Diabetes, 1997,46[ Supp1]2:S19 -25.
